Contagion Community: Recent Episodes
Contagion Connect
Contagion® Community delves into some of the social factors that create and widen healthcare disparities.
In surveying our audience, 75% of respondents viewed healthy equity as a major issue within medicine. Infectious disease often disproportionately occurs along the lines of ethnicity, race, class, education, sexual orientation, geographic location, and more. The entwined nature of healthcare inequity and social factors inhibits us from examining infectious disease objectively, which is why Contagion Community spotlights underserved populations.
Through interviews with experts, we will offer insights into the issues associated with healthcare inequities and examine which strategies and solutions are being deployed to overcome these issues.
Contagion Community is a marriage of major conversations occurring in hospitals, labs, academics, and communities.
In this Contagion News Network series, Clinical Care for Hospitalized ABSSSI Patients with Comorbidities, we're joined by Bruce Jones, PharmD, FIDSA, BCPS, who offers his commentary and thoughts on the clinical management of patients with acute bacterial skin and skin structure infections.
In Episode 4, the final segment, Jones offered his insights for when he considers discharging patients.
In this Contagion News Network series, Clinical Care for Hospitalized ABSSSI Patients with Comorbidities, we're joined by Bruce Jones, PharmD, FIDSA, BCPS, who offers his commentary and thoughts on the clinical management of patients with acute bacterial skin and skin structure infections.
In Episode 3, Jones covers concerns around empirical antimicrobial treatment and opportunities to narrow down therapies.
In this Contagion News Network series, Clinical Care for Hospitalized ABSSSI Patients with Comorbidities, we're joined by Bruce Jones, PharmD, FIDSA, BCPS, who offers his commentary and thoughts on the clinical management of patients with acute bacterial skin and skin structure infections.
In Episode 2, Jones offers clinical considerations for patient dosing and clinical management strategies associated with concurrent therapy.
In this Contagion News Network series, Clinical Care for Hospitalized ABSSSI Patients with Comorbidities, we're joined by Bruce Jones, PharmD, FIDSA, BCPS, who offers his commentary and thoughts on the clinical management of patients with acute bacterial skin and skin structure infections.
In Episode 1, Jones discusses treating challenging patients with comorbidities such as type 2 diabetes, higher BMI, and advanced age.
Christian Sandrock, MD, MPH, FCCP, highlights key takeaways on approaching treatment of antimicrobial resistant gram-negative infections as presented in updated IDSA guidelines and ID week 2023.
George Sakoulas, MD, provides key insights on the management of soft tissue infections including the role of single-dose agents and treating patients in an outpatient setting.
An expert in infectious diseases shares treatment considerations and clinical strategies for the management of community acquired pneumonia (CAP).
COVID-19 reshaped the landscape of urinary tract infections (UTIs). Explore the prevalence of resistant pathogens, the impact on infection prevention, and the changes in positive pathogens.
In this mini podcast, infectious diseases clinical pharmacy specialist Bruce M. Jones, PharmD, FIDSA, BCPS, breaks down the “very straightforward criteria” he uses to decide whether a skin and soft tissue infection (SSTI) patient should be inpatient or outpatient.
What steps need taken to end viral hepatitis by 2030? “It all comes down to testing,” said Carl Schmid, executive director of the HIV+Hepatitis Policy Institute.
Although the development of antibiotics remains a challenge, there are some legislative strategies that could make it more attractive and get more players involved.
On the fourth episode of the Contagion Community podcast, Evan Loh, MD, the CEO of Paratek Pharmaceuticals, discuses passing federal legislation to improve antibiotic development and reduce antimicrobial resistance.
People who use drugs face obstacles, like homelessness and stigma, that hinder their access to healthcare. Dr. Brianna Norton opened the Montefiore-NYHRE Clinic, a first-of its kind academic medical center, to serve marginalized people holistically and respectfully.
In this latest episode of Contagion Community, we interview Dr. Jacinda Abdul-Mutakabbir about vaccine equality vs vaccine equity as well as her experience on a COVID-19 vaccine drive to increase vaccinations in communities of color.
In this first episode of Contagion Community, we interview vaccine research scientist Dr. Leonard Friedland about vaccination disparities in the US and around the world.
In our exclusive interview, Kansagra, D’Souza, and Dholaria provided an in-depth look into the current state of cellular therapy in hematologic malignancies, the benefits and drawbacks of approved and investigational products, and new constructs for CAR T in multiple myeloma and lymphoma.
The Vanderbilt Professor of Preventive Medicine shares thoughts on the first potential COVID-19 vaccine.
Dr. Vivek Garg, CareMore and Aspire chief medical officer, discusses palliative home-based care and its effects of COVID-19 with Managed Healthcare Executive Assistant Editor, Briana Contreras.
Rebecca Dutch, PhD, professor of molecular and cellular biochemistry, discusses misconceptions about the SARS-CoV-2 virus, how the virus differs from other coronaviruses, and critical information that remains unknown.
Cidara Therapeutics is developing a new echinocandin called Rezafungin that's shown promise in clinical trials. Cidara is also developing a new anti-viral technology which isn't a vaccine, but could provide universal flu protection on a different basis. We talked to CEO Jeff Stein, PhD, about these therapies. After speaking with Dr. Stein, we hone in on Rezafungin in a chat with George Thompson, MD, associate professor of clinical medicine at the UC Davis School of Medicine. Dr. Thompson is an infectious disease clinician and an expert in the mycology field. He was an investigator in Cidara’s phase two trial of Rezafungin and is involved in the currently being enrolled phase three trial.
Follow Contagion®on Twitter.
Music credit: Joseph McDade
In this episode of Contagion® Connect, we'll bring you a voice from Nanjing, China. Seth Bourg is an American physics teacher who has been living in the city since August. He'll give us his unique insight on life under quarantine there, not only as an American, but as someone with the experience to compare the interruption to society with New Orleans during Hurricane Katrina.
For an interview transcript, visit Contagion®here.
Music credit: Joseph McDade
Welcome to Contagion® Connect. This podcast will bring you expert perspectives on trending infectious disease topics. First, we'll speak to John Johnson, project lead for Ebola vaccination in the Democratic Republic of the Congo with Médecins Sans Frontières France, for a perspective on how the new availability of vaccines has shaped the response to the ongoing epidemic compared to the West African Ebola outbreak.
Then, we'll speak with microbiologist Jason Kindrachuk, PhD, about his experience in Liberia during the West African epidemic. Kindrachuk is also an expert on current research pertaining to lasting effects in Ebola survivors, so we'll speak to him for a clinical perspective on what the future holds for those who survive the disease.
A transcript of the interview is available on Contagionlive.com
Follow Jason Kindrachuk, MSF, and Contagion®on Twitter.
Music credit: Joseph McDade
Welcome to Contagion® Connect. This new podcast will bring you expert perspectives on trending infectious disease topics.
In this episode, we feature a conversation with Timothy Ray Brown recorded at ANAC 2019 in Portland, Oregon. Brown became the first person to be cured of HIV after received a stem-cell transplant to treat leukemia. At first, he desired to remain anonymous and was referred to as the “Berlin Patient.” However, in 2010, Brown came forward and has become an advocate for people living with HIV. He hopes to see the day when all individuals when HIV can be cured safely.
https://www.contagionlive.com/news/contagion-connect-episode-4-timothy-ray-browns-advocacy-for-hiv-cure-research
Paul Abrams, MBA, director of Health Care Specialty Group at MJH Life Sciences, speaks with Vaibhav Singh, co-founder and CEO of Circle of Life, about his company’s product, Zevac, which aims to help clinicians make more informed prescribing decisions.
For a full transcript visit https://www.contagionlive.com/.
Welcome to Contagion® Connect. This new podcast will bring you expert perspectives on trending infectious disease topics. In this episode, we take a dual look at the recently announced changes to antibiotic reimbursements from the Centers for Medicare and Medicaid Services. First, we’ll speak to Dr. Susan Davis, an infectious disease pharmacist, about the impact from a clinician standpoint. Then we'll talk to Larry Edwards, CEO of Tetraphase Pharmaceuticals, for an industry perspective.
A transcript of the interview is available on ContagionLive.com.
Follow Contagion®on Twitter.
Music credit: Joseph McDade
Welcome to Contagion® Connect. This new podcast will bring you expert perspectives on trending infectious disease topics. In this episode, we are joined by Alexandra L. Phelan, SJD, LLM, LLB, from the Georgetown University Center for Global Health Science and Security. We will be discussing an editorial published in Nature regarding the impact of pandemic bonds on the ongoing Ebola outbreak and the Democratic Republic of the Congo.
A transcript of the interview is available on ContagionLive.com.
Follow Dr. Phelan and Contagion®on Twitter.
Music credit: Joseph McDade